Dana-Farber Cancer Institute shared a post on LinkedIn:
“We were honored to co-host the Innovations in Cancer Care Symposium (ICCS) this past weekend in Guangzhou with our colleagues at the First Affiliated Hospital of Sun Yat-sen University.
This year’s theme, ‘Systemic Crosstalk Driving Therapeutic Resistance and Tumor Metastasis,’ brought together leading clinicians and scientists to discuss pressing clinical challenges and emerging advances in:
- Mechanisms of treatment resistance.
- Diagnosis and management of metastasis.
- Translational strategies to improve patient outcomes.
We were honored to be joined by experts from leading institutions across China-including, Tsinghua University, Peking University, the Chinese Academy of Medical Sciences, and the The Chinese University of Hong Kong-alongside internationally recognized oncology scholars and editors from top journals.
Special thank you to the US Consulate office in Guangzhou for the ongoing support and engagement.”
Other articles about ICCS on OncoDaily.
